对老年抑郁症尺度,痴呆症版本 (GDS-D) 的初步调查
Joshua Flavell1, Kailas Roberts2, Philip L P Morris3
1The Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, 4072, Australia; The Mater Memory and Cognitive Disorders Clinic, The Mater Hospital, Raymond Terrace, South Brisbane, Queensland, 4101, Australia; Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, 4072, Australia.
Journal of affective disorders
|December 30, 2025
概括
一个新的10项老年抑郁量表 (GDS-D) 有效地选痴呆患者的抑郁症. 这种优化的工具在记忆诊所和痴呆症队列中显示出与所有以前的GDS版本相比的卓越准确性.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 抑郁症经常与痴呆症同时发生,由于症状重叠,诊断变得复杂.
- 老年抑郁量表 (GDS) 是一种常见的查工具,但其项目可能会在痴呆患者中混.
- 现有的GDS版本 (GDS-30,GDS-15,GDS-10,GDS-8,GDS-4) 包括有关认知,冷漠和未来前景的项目,这在痴呆症评估中可能是有问题的.
研究的目的:
- 开发和验证老年抑郁量表 (GDS-D) 的10项版本,专门用于诊断痴呆症抑郁症.
- 删除其他GDS版本中存在的混项目,这些项目可能会干扰痴呆症患者的精确抑郁评估.
主要方法:
- 对患有阿尔茨海默病 (AD),前性痴呆症 (FTLD) 和抑郁障碍的参与者的数据进行了回顾性分析.
- 参与者完成了GDS-30并使用精神疾病诊断和统计手册第五版 (DSM-5) 标准进行了精神病学评估.
- 将GDS-D的诊断准确性与所有以前的GDS版本进行了比较,使用灵敏度,特异性,正预测值 (PPV) 和负预测值 (NPV).
主要成果:
- 在记忆诊所和痴呆症 (AD和FTLD) 设置中,GDS-D显示出高诊断准确度,范围为92-97%.
- GDS-D的精度优于完整的GDS-30和所有较短的GDS版本.
- GDS-D成功排除了混物项,改善了痴呆症抑郁症查.
结论:
- GDS-D是一种有效的工具,可以在记忆诊所环境中加强抑郁症查,特别是在痴呆症患者中.
- 与现有的GDS版本相比,GDS-D在痴呆症队列中为抑郁症提供了更好的诊断性能.
- 建议进一步验证GDS-D在更大,更多样化的痴呆症人群中的实用性.
相关概念视频
01:15Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
926
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
926
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
174
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482